Type |
Details |
Score |
Publication |
First Author: |
Scheijen B |
Year: |
2003 |
Journal: |
Mol Cell Biol |
Title: |
Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation. |
Volume: |
23 |
Issue: |
10 |
Pages: |
3656-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wunderlich M |
Year: |
2002 |
Journal: |
Oncogene |
Title: |
Mdm2 inhibition of p53 induces E2F1 transactivation via p21. |
Volume: |
21 |
Issue: |
28 |
Pages: |
4414-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gnanasundram SV |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. |
Volume: |
8 |
Issue: |
1 |
Pages: |
2103 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taura M |
Year: |
2011 |
Journal: |
Nucleic Acids Res |
Title: |
MEF/ELF4 transactivation by E2F1 is inhibited by p53. |
Volume: |
39 |
Issue: |
1 |
Pages: |
76-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pierce AM |
Year: |
1998 |
Journal: |
Oncogene |
Title: |
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. |
Volume: |
16 |
Issue: |
10 |
Pages: |
1267-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zacksenhaus E |
Year: |
1993 |
Journal: |
Mol Cell Biol |
Title: |
A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. |
Volume: |
13 |
Issue: |
8 |
Pages: |
4588-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang C |
Year: |
2006 |
Journal: |
Nat Cell Biol |
Title: |
Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. |
Volume: |
8 |
Issue: |
9 |
Pages: |
1025-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fedele M |
Year: |
2006 |
Journal: |
Cell Div |
Title: |
E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression. |
Volume: |
1 |
|
Pages: |
17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou C |
Year: |
2009 |
Journal: |
Mol Endocrinol |
Title: |
E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors. |
Volume: |
23 |
Issue: |
12 |
Pages: |
2000-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Swiatnicki MR |
Year: |
2021 |
Journal: |
Sci Rep |
Title: |
Metastasis is altered through multiple processes regulated by the E2F1 transcription factor. |
Volume: |
11 |
Issue: |
1 |
Pages: |
9502 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wunderlich M |
Year: |
2004 |
Journal: |
Cell Cycle |
Title: |
MdmX represses E2F1 transactivation. |
Volume: |
3 |
Issue: |
4 |
Pages: |
472-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Palomer X |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells. |
Volume: |
6 |
Issue: |
5 |
Pages: |
e19724 |
|
•
•
•
•
•
|
Publication |
First Author: |
Olson MV |
Year: |
2007 |
Journal: |
Cancer Res |
Title: |
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. |
Volume: |
67 |
Issue: |
9 |
Pages: |
4005-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blais A |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. |
Volume: |
277 |
Issue: |
35 |
Pages: |
31679-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2005 |
Journal: |
Nucleic Acids Res |
Title: |
The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription. |
Volume: |
33 |
Issue: |
18 |
Pages: |
6024-33 |
|
•
•
•
•
•
|
Transgene |
Type: |
transgene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang B |
Year: |
2014 |
Journal: |
Hepatology |
Title: |
Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. |
Volume: |
59 |
Issue: |
2 |
Pages: |
555-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsumoto N |
Year: |
2004 |
Journal: |
Oral Microbiol Immunol |
Title: |
Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice. |
Volume: |
19 |
Issue: |
4 |
Pages: |
270-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mans DA |
Year: |
2013 |
Journal: |
J Pathol |
Title: |
Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients. |
Volume: |
231 |
Issue: |
1 |
Pages: |
117-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Haim Y |
Year: |
2017 |
Journal: |
Mol Metab |
Title: |
ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype. |
Volume: |
6 |
Issue: |
7 |
Pages: |
725-736 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gurha P |
Year: |
2016 |
Journal: |
Circ Res |
Title: |
Knockdown of Plakophilin 2 Downregulates miR-184 Through CpG Hypermethylation and Suppression of the E2F1 Pathway and Leads to Enhanced Adipogenesis In Vitro. |
Volume: |
119 |
Issue: |
6 |
Pages: |
731-50 |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Epigenetic involvement of Alien/ESET complex in thyroid hormone-mediated repression of E2F1 gene expression and cell proliferation. |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:29437 |
Assay Type: |
RNA in situ |
Annotation Date: |
2020-05-11 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3578426 |
Pattern: |
Regionally restricted |
Stage: |
TS26 |
Assay Id: |
MGI:6415734 |
Age: |
embryonic day 18.5 |
|
Note: |
Expressed in the core of the villus (lamina propria) and the adjacent epithelia, same as the E2f1 expression. |
Specimen Label: |
4 left |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:29437 |
Assay Type: |
RNA in situ |
Annotation Date: |
2020-05-11 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3578426 |
Pattern: |
Regionally restricted |
Stage: |
TS26 |
Assay Id: |
MGI:6415734 |
Age: |
embryonic day 18.5 |
|
Note: |
Expressed in the core of the villus (lamina propria) and the adjacent epithelia, same as the E2f1 expression. |
Specimen Label: |
4 right |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment. |
|
•
•
•
•
•
|
Publication |
First Author: |
Pickard A |
Year: |
2010 |
Journal: |
J Cell Sci |
Title: |
Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation. |
Volume: |
123 |
Issue: |
Pt 21 |
Pages: |
3718-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cartier J |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription. |
Volume: |
286 |
Issue: |
30 |
Pages: |
26406-17 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE71380 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 8, Snorri S Thorgeirsson |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Robertson KD |
Year: |
2000 |
Journal: |
Nat Genet |
Title: |
DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. |
Volume: |
25 |
Issue: |
3 |
Pages: |
338-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Johnson DG |
Year: |
1997 |
Journal: |
Mol Carcinog |
Title: |
High-affinity binding of the cell cycle-regulated transcription factors E2F1 and E2F4 to benzo[a]pyrene diol epoxide-DNA adducts. |
Volume: |
20 |
Issue: |
2 |
Pages: |
216-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou F |
Year: |
2008 |
Journal: |
J Biol Chem |
Title: |
The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. |
Volume: |
283 |
Issue: |
21 |
Pages: |
14506-15 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE71381 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 5, Rene Bernards |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Alb-E2F1)8Sst/? |
Background: |
involves: C57BL/6J * CBA/J |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang D |
Year: |
2001 |
Journal: |
Mol Carcinog |
Title: |
Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis. |
Volume: |
31 |
Issue: |
2 |
Pages: |
90-100 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Eric C Holland |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Rene Bernards |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, David G Johnson |
Allele Type: |
Transgenic |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Coulouarn C |
Year: |
2006 |
Journal: |
Hepatology |
Title: |
Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis. |
Volume: |
44 |
Issue: |
4 |
Pages: |
1003-11 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Uhrbom L |
Year: |
2004 |
Journal: |
Nat Med |
Title: |
Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. |
Volume: |
10 |
Issue: |
11 |
Pages: |
1257-60 |
|
•
•
•
•
•
|
Allele |
Name: |
E2F transcription factor 3; targeted mutation 5, Gustavo Leone |
Allele Type: |
Targeted |
Attribute String: |
Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(KRT5-E2F1)2Dgj/? |
Background: |
involves: C57BL/6 * SJL/J *SKH1 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Berton TR |
Year: |
2003 |
Journal: |
Oncogene |
Title: |
Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. |
Volume: |
22 |
Issue: |
35 |
Pages: |
5415-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Calvisi DF |
Year: |
2004 |
Journal: |
Lab Invest |
Title: |
Disregulation of E-cadherin in transgenic mouse models of liver cancer. |
Volume: |
84 |
Issue: |
9 |
Pages: |
1137-47 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
76
|
Fragment?: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The RB C-terminal domain is required for high-affinity binding to E2F-DP complexes and for maximal repression of E2F-responsive promoters, thereby acting as a growth suppressor by blocking the G1-S transition of the cell cycle. This domain has a strand-loop-helix structure, which directly interacts with both E2F1 and DP1, followed by a tail segment that lacks regular secondary structure []. |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
GEO |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Brca1/Brca1<+> Tg(KRT5-E2F1)2Dgj/? |
Background: |
involves: 129S6/SvEvTac * C57BL/6 * SJL |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee JS |
Year: |
2004 |
Journal: |
Nat Genet |
Title: |
Application of comparative functional genomics to identify best-fit mouse models to study human cancer. |
Volume: |
36 |
Issue: |
12 |
Pages: |
1306-11 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Cell division cycle-associated protein 7 (CDCA7/JPO1) is a transcription regulator whose expression is activated by c-Myc and by E2F1 []. CDCA7 can associate with Myc in a phosphorylation-dependent manner. CDCA7 phosphorylation by AKT leads to loss of its association with Myc []. This interaction affects Myc-dependent apoptosis and transformation [, , ]. CDCA7 has also been identified as a Notch target involved in hematopoietic stem cell emergence []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Calvisi DF |
Year: |
2005 |
Journal: |
J Hepatol |
Title: |
Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. |
Volume: |
42 |
Issue: |
6 |
Pages: |
842-9 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Brca1/Brca1 Tg(KRT5-E2F1)2Dgj/? |
Background: |
involves: 129S6/SvEvTac * C57BL/6 * SJL |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
E2f1/E2f1 E2f3/E2f3 |
Background: |
involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tmem163/? |
Background: |
involves: 129P2/OlaHsd * FVB * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gtf2ird1/Gtf2ird1<+> Tg(Alb-E2F1)8Sst/? |
Background: |
involves: C57BL/6 * CBA |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Goto Y |
Year: |
2006 |
Journal: |
Biochim Biophys Acta |
Title: |
JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. |
Volume: |
1759 |
Issue: |
1-2 |
Pages: |
60-8 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
192
|
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Gill RM |
Year: |
2013 |
Journal: |
Mol Cell Biol |
Title: |
The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation. |
Volume: |
33 |
Issue: |
3 |
Pages: |
498-513 |
|
•
•
•
•
•
|
Publication |
First Author: |
Prescott JE |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation. |
Volume: |
276 |
Issue: |
51 |
Pages: |
48276-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guiu J |
Year: |
2014 |
Journal: |
J Exp Med |
Title: |
Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence. |
Volume: |
211 |
Issue: |
12 |
Pages: |
2411-23 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE79451 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE13753 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Scheijen B |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
High incidence of thymic epithelial tumors in E2F2 transgenic mice. |
Volume: |
279 |
Issue: |
11 |
Pages: |
10476-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Calvisi DF |
Year: |
2004 |
Journal: |
Gastroenterology |
Title: |
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. |
Volume: |
126 |
Issue: |
5 |
Pages: |
1374-86 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Brca1/Brca1 Tg(KRT5-cre)5132Jlj/? Tg(KRT5-E2F1)2Dgj/? |
Background: |
involves: 129S6/SvEvTac * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Webster LC |
Year: |
1991 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Conversion of the E1A Cys4 zinc finger to a nonfunctional His2,Cys2 zinc finger by a single point mutation. |
Volume: |
88 |
Issue: |
22 |
Pages: |
9989-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chellappan S |
Year: |
1992 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. |
Volume: |
89 |
Issue: |
10 |
Pages: |
4549-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bellacchio E |
Year: |
2013 |
Journal: |
J Cell Physiol |
Title: |
Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery. |
Volume: |
228 |
Issue: |
2 |
Pages: |
285-91 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This group represents adenoviral early E1A proteins. The E1A protein is responsible for the transcriptional activation of the early genes with in the viral genome at the start of the infection process as well as some cellular genes [].E1A disrupts the function of host retinoblastoma protein RB1/pRb, which is a key regulator of the cell cycle []. It also induces the disassembly of the E2F1 transcription factors from RB1 by direct competition for the same binding site on RB1, with subsequent transcriptional activation of E2F1-regulated S-phase genes []. Inactivation of the ability of RB1 to arrest the cell cycle is critical for cellular transformation, uncontrolled cellular growth and proliferation induced by viral infection. The stimulation of the progression from G1 to S phase allows the virus to efficiently use the cellular DNA replicating machinery to achieve viral genome replication. |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang A |
Year: |
2005 |
Journal: |
Cancer Res |
Title: |
Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. |
Volume: |
65 |
Issue: |
13 |
Pages: |
5607-19 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
382
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ziebold U |
Year: |
2001 |
Journal: |
Genes Dev |
Title: |
E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. |
Volume: |
15 |
Issue: |
4 |
Pages: |
386-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ammirante M |
Year: |
2013 |
Journal: |
Genes Dev |
Title: |
An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence. |
Volume: |
27 |
Issue: |
13 |
Pages: |
1435-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ozawa T |
Year: |
2014 |
Journal: |
Cancer Cell |
Title: |
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. |
Volume: |
26 |
Issue: |
2 |
Pages: |
288-300 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iakova P |
Year: |
2011 |
Journal: |
Semin Cancer Biol |
Title: |
Intracellular signaling and hepatocellular carcinoma. |
Volume: |
21 |
Issue: |
1 |
Pages: |
28-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rodriguez-Jato S |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Drosophila melanogaster dHCF interacts with both PcG and TrxG epigenetic regulators. |
Volume: |
6 |
Issue: |
12 |
Pages: |
e27479 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dubrez-Daloz L |
Year: |
2008 |
Journal: |
Cell Cycle |
Title: |
IAPs: more than just inhibitors of apoptosis proteins. |
Volume: |
7 |
Issue: |
8 |
Pages: |
1036-46 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
138
|
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Mahajan SS |
Year: |
2000 |
Journal: |
Mol Cell Biol |
Title: |
Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP. |
Volume: |
20 |
Issue: |
3 |
Pages: |
919-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luciano RL |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
HCF-1 functions as a coactivator for the zinc finger protein Krox20. |
Volume: |
278 |
Issue: |
51 |
Pages: |
51116-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vogel JL |
Year: |
2000 |
Journal: |
EMBO J |
Title: |
The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP. |
Volume: |
19 |
Issue: |
4 |
Pages: |
683-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Piluso D |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Host cell factor-1 interacts with and antagonizes transactivation by the cell cycle regulatory factor Miz-1. |
Volume: |
277 |
Issue: |
48 |
Pages: |
46799-808 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vogel JL |
Year: |
2000 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Autocatalytic proteolysis of the transcription factor-coactivator C1 (HCF): a potential role for proteolytic regulation of coactivator function. |
Volume: |
97 |
Issue: |
17 |
Pages: |
9425-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vogel JL |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interaction with protein cofactors. |
Volume: |
103 |
Issue: |
18 |
Pages: |
6817-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gudkova D |
Year: |
2019 |
Journal: |
Nucleic Acids Res |
Title: |
HCF-2 inhibits cell proliferation and activates differentiation-gene expression programs. |
Volume: |
47 |
Issue: |
11 |
Pages: |
5792-5808 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kulathila R |
Year: |
2009 |
Journal: |
Acta Crystallogr D Biol Crystallogr |
Title: |
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9. |
Volume: |
65 |
Issue: |
Pt 1 |
Pages: |
58-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dueber EC |
Year: |
2011 |
Journal: |
Science |
Title: |
Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. |
Volume: |
334 |
Issue: |
6054 |
Pages: |
376-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Damgaard RB |
Year: |
2011 |
Journal: |
Discov Med |
Title: |
Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity. |
Volume: |
11 |
Issue: |
58 |
Pages: |
221-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Izeta A |
Year: |
2003 |
Journal: |
Gene |
Title: |
Primary structure and compartmentalization of Drosophila melanogaster host cell factor. |
Volume: |
305 |
Issue: |
2 |
Pages: |
175-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sabina RL |
Year: |
1989 |
Journal: |
Mol Cell Biol |
Title: |
Expression of three stage-specific transcripts of AMP deaminase during myogenesis. |
Volume: |
9 |
Issue: |
5 |
Pages: |
2244-6 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry includes Host cell factor 1 (HCF1) and Host cell factor 2 (HCF2) from humans. They contain an N-terminal kelch domain and a C-terminal FnIII domain. However, HCF2 is smaller than HCF-1, lacking the complete central region including the HCF1 specific repeats and as a result is not subject to proteolytic processing []. This entry also includes their Drosophila melanogaster homologue, dHCF, which is involved in both activation and repression of transcription during fly development []. Host cell factor homologue hcf-1 from C. elegans controls the cell cycle through mitotic histone phosphorylation modulation and negatively regulates responses to environmental stresses [].HCF1 is associated with the activation and repression of gene expression. It is brought to specific promoters by association with DNA-sequence-specific transcription factors such as Sp1, GABP, YY1, Ronin/THAP11, and E2F1 and E2F4 []. HCFC1 recruits and is a part of several different complexes, including the SET1 histone methyltransferase complex (transcription activation), the SIN3 histone deacetylase complex (transcription repression) [], the THAP1/THAP3-HCFC1-OGT complex (required for the regulation of the transcriptional activity of RRM1) [], and the NSL complex (acetylation of nucleosomal histone H4) [].HCF2 is involved in activation of differentiation and morphogenesis gene expression programs, and in parallel in inhibition of cellular growth and metabolism []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Host cell factor 1 (HCFC1) is associated with the activation and repression of gene expression. It is brought to specific promoters by association with DNA-sequence-specific transcription factors such as Sp1, GABP, YY1, Ronin/THAP11, and E2F1 and E2F4 []. HCFC1 recruits and is a part of several different complexes, including the SET1 histone methyltransferase complex (transcription activation), the SIN3 histone deacetylase complex (transcription repression) [], the THAP1/THAP3-HCFC1-OGT complex (required for the regulation of the transcriptional activity of RRM1) [], and the NSL complex (acetylation of nucleosomal histone H4) []. This entry includes mammalian HCFC1 and the Drosophila homologue, dHCF. They undergo a process of proteolytic maturation to produce a heterodimeric complex of HCF-N and HCF-C subunits, by different enzymes, O-GlcNAc transferase and taspase1, respectively [, ]. They share a Kelch domain, regions biased for basic (Basic) or acidic (Acidic) amino acids, fibronectin type 3 repeats, and a nuclear localization signal [].During human herpes simplex virus infection, HCFC1 forms a multiprotein-DNA complex enabling transcription of the virus's early genes []. It is also a co-activator of EGR2/Krox20 []and the GA-binding protein GABP2 [], and represses ZBTB17/Miz-1 []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The entry represents the UBA domain found in c-IAPs, including BIRC2 (also known as C-IAP1) and BIRC3 (also known as C-IAP2). c-IAPs function as ubiquitin E3 ligases that mediate the ubiquitination of the substrates involved in apoptosis, nuclear factor-kappaB (NF-kappaB) signaling, and oncogenesis [, ]. Unlike other apoptosis proteins such as XIAP, c-IAPs exhibit minimal binding to caspases and may not play an important role in the inhibition of these proteases. c-IAP1 is a potent regulator of the tumor necrosis factor (TNF) receptor family and NF-kappaB signaling pathways in the cytoplasm. It can also regulate E2F1 transcription factor-mediated control of cyclin transcription in the nucleus []. c-IAP2 also influences ubiquitin-dependent pathways that modulate innate immune signalling by activation of NF-kappaB []. c-IAPs contain three N-terminal baculoviral IAP repeat (BIR) domains that enable interactions with proteins, a ubiquitin-association (UBA) domain that is responsible for the binding of polyubiquitin (polyUb), a caspase activation and recruitment domain (CARD) that serves as a protein interaction surface, and a RING domain at the carboxyl terminus that is required for ubiquitin ligase activity [, ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry includes CDCA7 and CDA7L.Cell division cycle-associated protein 7 (CDCA7/JPO1) is a transcription regulator whose expression is activated by c-Myc and by E2F1 []. CDCA7 can associate with Myc in a phosphorylation-dependent manner. CDCA7 phosphorylation by AKT leads to loss of its association with Myc []. This interaction affects Myc-dependent apoptosis and transformation [, , ]. CDCA7 has also been identified as a Notch target involved in hematopoietic stem cell emergence [].Cell division cycle-associated 7-like protein (CDCA7L/JPO2/R1) is closely related to CDCA7/JPO1; and like CDCA7, it plays a role in transcriptional regulation and interacts with c-Myc []. JPO2 overexpression induces metastasis in medulloblastoma []. JPO2 can interact directly and dynamically with chromatin, the dynamics of JPO2 chromatin binding being decelerated upon interaction with LEDGF/p75, which binds and tethers JPO2 to chromatin [, ].JPO2 inhibits monoamine oxidase A (MAOA) activity and gene expression by binding to the promoter []. JPO2 and MAOA act upstream of cyclin D1 and E2F1, and are involved in apoptotic signalling pathways []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Li J |
Year: |
2008 |
Journal: |
Dev Cell |
Title: |
Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. |
Volume: |
14 |
Issue: |
1 |
Pages: |
62-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang A |
Year: |
2001 |
Journal: |
Genomics |
Title: |
Molecular cloning and characterization of a novel mouse epidermal differentiation gene and its promoter. |
Volume: |
73 |
Issue: |
3 |
Pages: |
284-90 |
|
•
•
•
•
•
|